Medication info
Tenel M Sustained-Release Tablets 10/750 mg

Tenel M Sustained-Release Tablets 10/750 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›750mg / 1 tablet
Manufacturer / importer
Medica Korea Co., Ltd.
Appearance
Yellow oval-shaped sustained-release film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201310 · Approved 2022.04.04 · Insurance code 646005500

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. In patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. In patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the patient's current doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, blood glucose control should be closely monitored, and the dose should be adjusted as appropriate. When co-administered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering agents. Because such a change may lead to changes in blood glucose control, any changes in the treatment of patients with type 2 diabetes mellitus should be made under careful monitoring. To maintain its extended-release properties, this medicine should be swallowed whole and not split, crushed, ground, or chewed.

Ingredients

Manufacturer
Medica Korea Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication helps regulate blood sugar levels in patients with type 2 diabetes by using Teneligliptin and Metformin together. It is used to effectively improve blood sugar levels in conjunction with diet and exercise therapy.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. In patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. In patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the patient's current doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, blood glucose control should be closely monitored, and the dose should be adjusted as appropriate. When co-administered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering agents. Because such a change may lead to changes in blood glucose control, any changes in the treatment of patients with type 2 diabetes mellitus should be made under careful monitoring. To maintain its extended-release properties, this medicine should be swallowed whole and not split, crushed, ground, or chewed.

Precautions

This medication helps control blood sugar levels. However, it can very rarely cause a dangerous condition known as lactic acidosis, which requires caution. Lactic acidosis occurs when lactic acid accumulates excessively in the body and can be life-threatening in severe cases. Additionally, hypoglycemia can occur when taking this medication with insulin or other diabetes medications, so blood sugar status should be monitored closely. This medication should not be administered to patients with moderate or severe renal impairment. Patients with very poor cardiac function or acute kidney disease should not use this medication. If undergoing tests using radiologic iodine contrast agents, this medication should be stopped at least 48 hours prior to the test, and resumed only after confirming normal renal function post-examination. This medication is not used for type 1 diabetes patients or patients with diabetic ketoacidosis. Also, any patient who has had an allergic reaction to any components of this medication should avoid using it. In cases of severe infection, serious injury, before and after surgery, the use of this medication should be temporarily halted, and it should be resumed after renal function returns to normal. It is advisable for individuals with very poor nutritional status or impaired liver function, and those who consume alcohol excessively to avoid this medication. Pregnant women or women who may become pregnant should not take this medication, and breastfeeding mothers should consult their healthcare professional. During treatment with this medication, patients should be well aware of hypoglycemia symptoms and take immediate appropriate actions if symptoms appear. Additionally, this medication can cause side effects such as bowel obstruction, liver dysfunction, pneumonia, skin rashes, acute pancreatitis; if any of these symptoms occur, immediate consultation with a physician is necessary. Elderly patients may have reduced renal function, so regular kidney function tests should be conducted, and dose adjustments may be necessary. In case of overdose, immediate medical attention should be sought, and if necessary, blood dialysis may be performed to remove the drug. This medication has not established safety and efficacy in children, thus it is not used in pediatric patients. When storing the medication, it should be kept out of reach of children and not transferred to other containers. Finally, patients should avoid alcohol during treatment and consult their healthcare provider or pharmacist when combining with other medications.

Side effects

Severe lactic acidosis, severe hypoglycemia, hypoglycemia, constipation, intestinal obstruction, liver dysfunction, interstitial pneumonia, dermatomyositis, acute pancreatitis, dizziness, abdominal distension, abdominal discomfort, nausea, abdominal pain, bloating, stomatitis, gastric polyp, colon polyp, duodenal ulcer, gastroesophageal reflux disease, diarrhea, appetite loss, amylase elevation, lipase elevation, AST (GOT) elevation, ALT (GPT) elevation, GGT elevation, ALP elevation, proteinuria, ketonuria, potential hematuria, eczema, rash, itching, allergic dermatitis, arthralgia, CK (CPK) elevation, serum potassium level elevation, fatigue, allergic rhinitis, serum uric acid elevation, peripheral edema, shingles, limb pain, upper abdominal pain, gastritis, upper respiratory infection, tremor, headache, asthenia, hunger, fatigue, facial edema, dyspepsia, nausea, viral upper respiratory infection, rhinitis, cold sweat, diabetic retinopathy, visual impairment, cough, pulmonary congestion, dyspnea, drug overdose, benign prostatic hyperplasia, headache, diarrhea, chronic gastritis, irritable bowel syndrome, fatigue, cerebral infarction, hyperglycemia, liver biopsy, neutropenia, blood sugar abnormalities, increased blood sugar, increased blood pressure, hepatic coma, lumbar spinal canal stenosis, intervertebral disc protrusion in the spine, intervertebral disc disorder in the spine, spinal ligament ossification, intervertebral foramen stenosis, rotator cuff syndrome, bladder mass, ureterolithiasis, urinary stones, coronary artery disease, unstable angina, gastroesophageal reflux disease, gastric polyps, gastritis, bile duct obstruction, chronic cholecystitis, soft tissue infection, pneumonia, cataract, depression, iliac artery stenosis, dizziness, benign prostatic hyperplasia, knee surgery, dizziness, diabetic neuropathy, paresthesia, muscle weakness, back pain, limb pain, lumbar spinal canal stenosis, tendinitis, cervical pain, bone pain, osteoarthritis, osteoporosis, muscle spasm, foot deformity, hypertrophic osteoarthritis, bursitis, spinal osteoarthritis, intervertebral disc protrusion in the spine, intervertebral disc disorder in the spine, spinal ligament ossification, intervertebral foramen stenosis, postmenopausal osteoporosis, rotator cuff syndrome, gastroenteritis, vomiting, chronic gastritis, upper abdominal pain, mouth pain, gastrointestinal motility disorder, decreased gastrointestinal motility, enteritis, toothache, anal rectal discomfort, acquired mixed hyperlipidemia, hypertriglyceridemia, vitamin D deficiency, abnormal weight gain, essential hypertension, orthostatic hypotension, white coat hypertension, hemorrhage, increased blood sugar, abnormal sputum, toxic hepatitis, non-alcoholic fatty liver disease, alcoholic liver disease, eyelid damage, ligament sprain, lip damage, bruise, urticaria, glaucoma, blurred vision, age-related macular degeneration, hyperthyroidism, hyperparathyroidism, coronary artery disease, unstable angina, angina, otalgia, dizziness, iron deficiency anemia, food allergy, pressure ulcer

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container that does not allow air in, preferably at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the medication's efficacy over time.

Appearance and packaging

Appearance

Yellow oval-shaped sustained-release film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.